PSY34 COST-EFFECTIVENESS OF TAPENTADOL PROLONGED-RELEASE (PR) COMPARED TO OXYCODONE AND MORPHINE IN PATIENTS WITH CHRONIC MODERATE TO SEVERE NON-CANCER PAIN IN SWEDEN
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72983-7
https://www.valueinhealthjournal.com/article/S1098-3015(11)72983-7/fulltext
Title :
PSY34 COST-EFFECTIVENESS OF TAPENTADOL PROLONGED-RELEASE (PR) COMPARED TO OXYCODONE AND MORPHINE IN PATIENTS WITH CHRONIC MODERATE TO SEVERE NON-CANCER PAIN IN SWEDEN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72983-7&doi=10.1016/S1098-3015(11)72983-7
First page :
A466
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
1141